Gynecologic Cancers

Benign Hematology

Questions discussed in this category

How do you determine duration of anticoagulation for an ovarian vein thrombosis following a provoking event?

1 Answer available

In which patients with oncologic or hematologic disorders are you recommending a 3rd dose of mRNA COVID vaccine?

2 Answers available

What are the current official guidelines regarding COVID-19 vaccination for patients with cancer or for hematologic conditions?

2 Answers available

Do you routinely prophylactically anticoagulate patients undergoing systemic chemotherapy outside of the perioperative period?

1 Answer available

Papers discussed in this category

Blood, 2008-05-15

Development and validation of a predictive model for chemotherapy-associated thrombosis.

The New England journal of medicine, 2019-02-21

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.

J Thromb Haemost, 2019 Jul 28

The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH.

N Engl J Med, 2018 Dec 04

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.

Ann Oncol, 2021 Mar 18

Association of Clinical Factors and Recent Anti-Cancer Therapy with COVID-19 Severity among Patients with Cancer: A Report from the COVID-19 and Cancer Consortium.

Blood Adv, 2017 Jun 22

Ovarian vein thrombus: to treat or not to treat?

Related Topics in Gynecologic Cancers